Dec 07, 2021 / 03:00PM GMT
Matthew Rothman -
Good morning. I'm Matthew Rothman. Counsel for Aclaris. Before we begin our prepared remarks I would like to remind you that the various statements we make during this call about the company's future results of operations and financial position, business strategy and plans and objectives for Aclaris' future operations are considered forward-looking statements within the meaning of the federal securities laws. Our forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties that could cause actual results to differ materially from those reflected in such statements.
These risks are described in the Risk Factors section of Aclaris' Form 10-K for the year ended December 31, 2020, and other filings Aclaris makes with the SEC from time to time. These documents are available under the SEC filings page of the Investors section of Aclaris' website at www.aclaristx.com. All of the information we provide on this call is provided as of today, and we
Aclaris Therapeutics Inc R&D Day (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers